Table.
Covariate | CRE Odds Ratio (95% CI) |
P Value | CP-CRE Odds Ratio (95% CI) |
P Value |
---|---|---|---|---|
On Contact Precautions | 2.18 (1.50 – 3.15) | <0.001 | 2.93 (1.28 – 6.72) | 0.01 |
Indication(s)a: | 1.00 | N/A | 1.00 | N/A |
MRSA | 1.68 (0.90 – 3.13) | 0.01 | 1.60 (0.38 – 6.77) | 0.52 |
VRE | 1.38 (0.75 – 2.54) | 0.30 | 1.31 (0.35 – 4.97) | 0.69 |
MDRGN | 3.42 (1.83 – 6.36) | <0.001 | 2.20 (0.54 – 9.02) | 0.27 |
CRE | 3.31 (0.58 – 18.87) | 0.18 | 8.95 (0.96 – 83.60) | 0.05 |
C. diff | 1.05 (0.43 – 2.55) | 0.92 | 0.82 (0.06 – 12.0) | 0.88 |
Resp. Virus | 0.60 (0.20 – 1.74) | 0.34 | (No observations) | N/A |
Other | 0.68 (0.34 – 1.33) | 0.26 | 1.24 (0.34 – 4.50) | 0.74 |
Abbreviations: CI, Confidence Interval; MRSA, Methicillin-resistant Staphylococcus aureus; VRE, Vancomycin-resistant Enterococcus; MDRGN, Multidrug-resistant Gram-negative; C. diff, Clostridioides difficile; Resp. Virus, Respiratory virus.
Indications analyses restricted to patients who were on contact precautions at admission.